Abstract
Purpose
Unaided and abrupt cessation of opiate use without drug substitution and step-down, referred to as “cold turkey,” is a common and difficult process for substance users, and is associated with several withdrawal symptoms and complications. This report presents a preliminary series of patients treated at an urban public hospital with acute perforation of peptic ulcers following abrupt cessation of long-term opiate use, a phenomenon that has not been previously described in the literature.
Methods
Thirty-five patients with acute gastroduodenal perforation and a history of opiate addiction with a recent and abrupt cessation of opiate use were admitted between February 2004 and October 2008. This study evaluated the demographics, antecedent drug use, substance use characteristics, previous medical or surgical treatment of peptic ulcer disease, and surgical findings.
Results
The mean age was 32.3 years (range, 21–41 years) and the patients were overwhelmingly male (94%). The most frequent agent in single opiate users was opium (62.9%) followed by heroin (22.9%). The time interval between opiate cessation and perforation onset was 2–65 days (mean, 6.1 days). All patients underwent an immediate exploratory laparotomy, and the majority of perforations were found to be in the postpyloric area (94%) with mean size of 4.3 × 5.1 mm. Two patients (6%) had perforations in the lesser curvature of the stomach.
Conclusion
All of the perforations occurred following sudden self-cessation without step-down or classic maintenance therapy, and this may prove the importance of supervised medical detoxification with special attention to gastroprotective agents such as antacid drugs.
Similar content being viewed by others
References
Svanes C. Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis. World J Surg 2000;24:277–283.
Tørring ML, Riis A, Christensen S, Thomsen RW, Jepsen P, Søndergaard J, et al. Perforated peptic ulcer and short-term mortality among tramadol users. Br J Clin Pharmacol 2008;65:565–572.
Sharma R, Organ CH Jr, Hirvela ER, Henderson VJ. Clinical observation of the temporal association between crack cocaine and duodenal ulcer perforation. Am J Surg 1997;174:629–632.
Reinbach DH, Cruickshank G, McColl KEL. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993;34:1344.
Gyires K. Morphine inhibits the ethanol-induced gastric damage in rats. Arch Int Pharmacodyn Ther 1990;306:170–181.
Tazi-Saad K, Chariot J, Vatier J, Del Tacca M, Rozé C. Antisecretory and anti-ulcer effects of morphine in rats after gastric mucosal aggression. Eur J Pharmacol 1991;192:271–277.
Gyires K, Fürst S, Farczádi E, Márton A. Morphine potentiates the gastroulcerogenic effect of indometacin in rats. Pharmacology 1985;30:25–31.
Parmar NS, Tariq M, Ageel AM. Studies on the possible mechanism of morphine-induced potentiation of the gastroulcerogenic effect of indomethacin in rats. Arch Int Pharmacodyn Ther 1987;289:149–160.
Gyires, K. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur. J. Pharmacol 1994;255:33–37.
Morley JE, Levine AS, Silvis SE. Endogenous opiates and stress ulceration. Life Sci 1982;31:693–699.
Gyires K. Are all “cytoprotective” drugs gastroprotective? Acta Physiol Hung 1992;80:247–255.
Bhounsule SA, D’souza RS, Dhume VG. Gastric cytoprotective effect of morphine is probably not mediated by mA-receptors. Arch Int Pharmacodyn Ther 1994;328:99–105.
Allen A, Carrol NJH. Adherent and soluble mucus in the stomach and duodenum. Dig Dis Sci 1985;30:55–62.
Allen A, Hutton DA, Leonard AJ, Pearson JP, Sellers LA. The role of mucus in the protection of the gastroduodenal mucosa. Scand J Gastroenterol 1986;21:71–77.
Cho CH, Wu KK, Wu S, Wong TM, So WH, Liu ES, et al. Morphine as a drug for stress ulcer prevention and healing in the stomach. Eur J Pharmacol 2003;460:177–182.
Aase S. Disturbances in the balance between aggressive and protective factors in the gastric and duodenal mucosa. Scand J Gastroenterol 1989;24:17–23.
Gyires K, Müllner K, Fürst S, Rónai AZ. Alpha-2 adrenergic and opioid receptor-mediated gastroprotection. J Physiol (Paris) 2000;94:117–121.
Wakayama T, Ishizaki Y, Mitsusada M, Takahashi S, Wada T, Fukushima Y, et al. Risk factors influencing the short-term results of gastroduodenal perforation. Surg Today 1994;24:681–687.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kahrom, M., Kahrom, H. Perforation of peptic ulcer following abrupt cessation of long-term opiate use. Surg Today 40, 836–839 (2010). https://doi.org/10.1007/s00595-009-4147-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-009-4147-x